All practice questions

8270 questions

Question 3161Question →

A 69-year-old man is evaluated in the hospital after being admitted for urosepsis. Over the past 24 hours, he has become profoundly confused and agitated, attempting to strike the nursing staff and pull out his intravenous lines. His medical history is significant for an 11-month history of progressive cognitive decline. His wife reports that over the past year, he has had episodes of staring blankly for prolonged periods, recurrently claims to see small animals running across the living room floor, and frequently kicks and thrashes while asleep. Physical examination earlier in the admission revealed increased resistance to passive movement in all four extremities and a slow, shuffling gait. The primary team decides that pharmacological intervention is urgently necessary to prevent the patient from harming himself and staff. Administration of which of the following medications is most likely to provoke a severe, potentially fatal deterioration characterized by extreme rigidity and autonomic dysfunction in this patient?

Show answer & explanation

Answer: Haloperidol

Answer

Haloperidol
The correct answer is haloperidol. The patient's baseline history of fluctuating cognition (staring blankly), formed visual hallucinations (seeing small animals), REM sleep behavior disorder (kicking/thrashing while asleep), and parkinsonism (rigidity, shuffling gait) is highly characteristic of Dementia with Lewy Bodies (DLB). Currently, he is experiencing delirium secondary to urosepsis. Patients with DLB have a profound, well-documented sensitivity to neuroleptic medications, particularly typical antipsychotics with strong dopamine (D2) receptor antagonism. Administration of haloperidol in these patients can precipitate a severe, potentially fatal neuroleptic sensitivity reaction. This reaction is characterized by irreversible worsening of parkinsonism, extreme rigidity, impaired consciousness, and severe autonomic dysfunction (resembling neuroleptic malignant syndrome).

Step-by-Step Solution

1
Identify the patient's underlying primary neurocognitive disorder based on the historical and physical findings.
The patient has an 11-month history of fluctuating cognition, visual hallucinations, REM sleep behavior disorder, and parkinsonism, which firmly points to a diagnosis of Dementia with Lewy Bodies (DLB).
Accurately diagnosing the baseline neurocognitive condition is essential to guide safe pharmacological management of the superimposed acute delirium.
2
Recognize the specific pharmacological contraindications uniquely associated with this baseline diagnosis.
Patients with DLB have a profound, potentially fatal sensitivity to dopamine D2 receptor antagonists, particularly first-generation (typical) antipsychotics.
Exposure to these agents can precipitate irreversible motor deterioration, severe rigidity, and autonomic instability resembling neuroleptic malignant syndrome.
3
Evaluate the given medication options to identify the contraindicated agent.
Haloperidol is a high-potency typical antipsychotic and carries the highest risk of causing this severe neuroleptic sensitivity reaction.
Identifying the most dangerous medication ensures patient safety and avoids iatrogenic morbidity during acute behavioral disturbances.

Key Concept

Patients with Dementia with Lewy Bodies (DLB) have an extreme sensitivity to neuroleptics, particularly typical antipsychotics like haloperidol, which can precipitate life-threatening motor and autonomic deterioration.
Estimated Time:1m 15s
Question 3162Question →

A 35-year-old male teacher presents to the primary care clinic accompanied by his sister. He reports a 6-week history of profound sadness, excessive sleepiness, and a 6-kg (13.2-lb) weight gain. He states, "I am a terrible person. I am directly responsible for the recent earthquake in South America." His sister expresses deep concern about his withdrawal from family. When asked about his past psychiatric history, his sister notes that three years ago, he had a distinct 7-day period where he was extraordinarily energetic, spoke rapidly, slept only two hours a night, and wrote an entire 300-page manuscript in a few days. He was not hospitalized at that time. He has no other medical conditions and takes no medications. Vital signs are within normal limits. Mental status examination reveals a disheveled man with psychomotor retardation, downcast gaze, and restricted affect. His speech is slow but coherent. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate quetiapine

Answer

The most appropriate next step is to initiate quetiapine, which will treat both the bipolar depression and the psychotic features.
The correct intervention is initiating quetiapine. The patient has Bipolar I Disorder, currently presenting with an acute major depressive episode with psychotic features (delusions of guilt). Quetiapine is an atypical antipsychotic that is FDA-approved as a first-line monotherapy for bipolar depression, and it simultaneously treats the psychotic symptoms.

Step-by-Step Solution

1
Identify the primary underlying psychiatric disorder from the patient's history.
The patient had a past 7-day episode of elevated energy, decreased need for sleep, rapid speech, and increased goal-directed activity. This meets the criteria for a manic episode, establishing a diagnosis of Bipolar I Disorder.
A single manic episode is sufficient to diagnose Bipolar I Disorder, regardless of whether the patient was hospitalized.
2
Characterize the current acute presentation.
The patient has a 6-week history of depressed mood, hypersomnia, and weight gain, accompanied by delusions of guilt (believing he caused an earthquake).
This constellation of symptoms indicates an acute major depressive episode with mood-congruent psychotic features.
3
Select the appropriate pharmacotherapy.
Treatment must target both severe bipolar depression and psychosis without risking a manic switch. Quetiapine is a first-line agent approved for bipolar depression that provides both mood-stabilizing and antipsychotic effects.
Standard antidepressants (SSRI/SNRI monotherapy) can induce mania in bipolar patients. Antipsychotic monotherapies like quetiapine, lurasidone, or cariprazine are the standard of care for this presentation.

Key Concept

Management of acute bipolar depression with psychotic features
Estimated Time:1m 30s
Question 3163Question →

A 38-year-old woman with a history of severe social anxiety disorder and treatment-resistant panic disorder is brought to the emergency department by her roommate due to severe agitation, shivering, and confusion. She has been maintained on phenelzine for the past year. Three days ago, her primary care physician prescribed a new daily medication to better manage her ongoing anxiety symptoms, instructing her to stop the phenelzine immediately and start the new drug. Vital signs show a temperature of 39.2°C (102.5°F), blood pressure of 165/100 mm Hg, and pulse of 118/min. Physical examination reveals diaphoresis, dilated pupils, and prominent bilateral clonus in the lower extremities. Which of the following medications was most likely prescribed by the primary care physician?

Show answer & explanation

Answer: Sertraline

Answer

Sertraline
The correct answer is sertraline. The patient's presentation of hyperthermia, autonomic instability, altered mental status, and prominent neuromuscular irritability (specifically clonus and hyperreflexia) is the classic triad of serotonin syndrome. This life-threatening condition is most frequently caused by the concurrent use of multiple serotonergic agents. Phenelzine is a monoamine oxidase inhibitor (MAOI). When switching a patient from an MAOI to a selective serotonin reuptake inhibitor (SSRI) like sertraline, a minimum 14-day washout period is absolutely required to allow for the regeneration of the monoamine oxidase enzyme. The primary care physician's instruction to switch immediately precipitated a massive accumulation of serotonin.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and physical examination findings.
The patient exhibits autonomic instability (fever, tachycardia, diaphoresis), altered mental status, and notable neuromuscular irritability (hyperreflexia, clonus).
To recognize the classic triad of symptoms indicative of serotonin syndrome.
2
Review the medication history and recent changes.
The patient was on phenelzine (an MAOI) and was immediately switched to a new medication without a necessary washout period.
To identify the pharmacological mechanism precipitating the acute toxidrome.
3
Determine which class of medication could interact with an MAOI to cause this syndrome.
Selective serotonin reuptake inhibitors (SSRIs) like sertraline strongly interact with MAOIs and require a 14-day washout period to prevent serotonin syndrome.
To select the correct medication from the given options that explains the clinical picture.

Key Concept

Serotonin syndrome is a potentially life-threatening condition caused by excess serotonergic activity, frequently precipitated by combining an MAOI with an SSRI without an adequate 14-day washout period; it classically presents with autonomic instability, altered mental status, and neuromuscular irritability (clonus).
Question 3164Question →

A 62-year-old postmenopausal woman is diagnosed with a 1.8-cm, estrogen receptor-positive, progesterone receptor-positive, HER2-negative invasive ductal carcinoma of the right breast via core needle biopsy. Clinical examination and preoperative imaging reveal no evidence of axillary lymphadenopathy or distant metastases. The patient elects to undergo breast-conserving therapy. Arrange the following management and therapeutic steps in the most appropriate chronological order for this patient's definitive care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Surgery → Multigene assay → Chemotherapy → Radiation therapy → Endocrine therapy.
The definitive management of early-stage, hormone receptor-positive, HER2-negative breast cancer follows a specific chronological sequence to optimize survival and minimize toxicity. Breast-conserving surgery with sentinel lymph node biopsy is performed first for local control and staging. The excised tumor tissue is then sent for multigene expression profiling (e.g., 21-gene assay) to determine the risk of distant recurrence and the expected benefit of chemotherapy. If chemotherapy is indicated, it is administered prior to radiation therapy to promptly address any systemic micrometastatic disease. Following the completion of chemotherapy, whole-breast radiation therapy is administered to eliminate any residual local microscopic disease, which is a mandatory component of breast-conserving therapy. Finally, adjuvant endocrine therapy (e.g., an aromatase inhibitor) is initiated for long-term suppression of estrogen-stimulated micrometastases.

Step-by-Step Solution

1
Identify the patient's diagnosis and chosen treatment pathway.
The patient has early-stage ER+/PR+/HER2- breast cancer and desires breast-conserving therapy.
This establishes the need for surgery followed by a sequence of adjuvant treatments to prevent local and systemic recurrence.
2
Determine the initial intervention.
Breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy is the first step.
For early-stage, clinically node-negative disease without indications for neoadjuvant therapy, upfront surgical resection and axillary staging are standard.
3
Determine how to risk-stratify the tumor for systemic therapy.
Perform a multigene expression assay on the surgical specimen.
In ER+/HER2- early-stage breast cancer, a multigene assay (e.g., 21-gene Oncotype DX) is performed on the excised tissue to guide the decision for adjuvant chemotherapy.
4
Sequence the adjuvant therapies.
Chemotherapy (if indicated) → Radiation therapy → Endocrine therapy.
Systemic chemotherapy must be given first to target micrometastases early. Radiation follows to consolidate local control. Endocrine therapy provides long-term systemic suppression and typically follows chemotherapy.

Key Concept

The standard sequence of breast-conserving therapy for early-stage hormone-receptor-positive breast cancer is upfront surgery, followed by multigene assay risk stratification, then chemotherapy (if indicated), followed by whole-breast radiation, and finally long-term endocrine therapy.
Question 3165Question →

A 61-year-old man, currently in remission from colon cancer, is evaluated in the oncology survivorship clinic for a 2-month history of pervasive low mood, anhedonia, severe fatigue, and feelings of worthlessness. He is not currently taking any psychiatric medications and has no prior psychiatric history. Based on standard psychiatric guidelines for the stepped-care management of Major Depressive Disorder (MDD), arrange the following clinical steps in the most appropriate chronological sequence, assuming the patient exhibits inadequate responses to initial treatments and eventually develops life-threatening clinical features.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with screening for medical causes and bipolar disorder, followed by initiating an SSRI, titrating the dose for a partial response, augmenting the regimen for non-response, and ultimately referring for ECT if life-threatening inanition develops.
The standard stepped-care algorithm for Major Depressive Disorder begins with ruling out medical mimics (e.g., hypothyroidism) and screening for bipolar disorder. Once unipolar MDD is confirmed, first-line treatment is typically an SSRI with a 4-to-6-week follow-up. If a partial response occurs, dose optimization is the appropriate next step before abandoning the drug. If treatment resistance persists after a maximized dose, augmentation with an agent like an atypical antipsychotic or bupropion is indicated. Finally, ECT is reserved for refractory cases or emergent, life-threatening complications such as inanition (food/fluid refusal), severe suicidality, or catatonia.

Step-by-Step Solution

1
Determine the necessary initial psychiatric and medical evaluation steps for a new onset depressive episode.
Identify the need to evaluate thyroid function and screen for bipolar disorder (prior hypomania/mania).
Medical mimics must be ruled out, and unrecognized bipolar disorder can be worsened by antidepressant monotherapy.
2
Select the appropriate initial pharmacotherapy for unipolar Major Depressive Disorder.
Identify the initiation of an SSRI (e.g., sertraline) and schedule follow-up in 4 to 6 weeks.
SSRIs are first-line treatments, and an adequate time frame is required to assess the initial clinical response.
3
Determine the next management step for a partial response to an initial antidepressant trial.
Identify dose titration to the maximum tolerated level.
Dose optimization is indicated before switching or augmenting when a patient shows partial improvement on a tolerated agent.
4
Select the appropriate intervention for treatment resistance following a maximized monotherapy trial.
Identify augmentation with an adjunctive agent, such as aripiprazole.
Augmentation is recommended when a patient fails to remit despite an optimized dose of first-line monotherapy.
5
Determine the definitive treatment for severe MDD complicated by life-threatening features.
Identify urgent electroconvulsive therapy (ECT).
ECT is the most rapid and effective intervention for severe depression complicated by inanition (food/fluid refusal) or catatonia.

Key Concept

Stepped-care management of Major Depressive Disorder (MDD)
Question 3166Question →

Match each clinical presentation of an adverse drug reaction in a patient treated for bipolar disorder to the most likely responsible psychotropic medication.

Click a left item, then click its matching right item

Items

A 34-year-old woman evaluated in the ED for severe polyuria and weakness. Past psychiatric history is significant for bipolar I disorder on maintenance therapy. Physical exam shows dry mucous membranes. Labs reveal a non-anion gap metabolic acidosis and a urine osmolality of 150 mOsm/kg that remains unchanged after exogenous desmopressin administration.
A 28-year-old man presents to urgent care with acute nystagmus, diplopia, and severe ataxia. He has bipolar disorder stable on a mood stabilizer but was prescribed clarithromycin three days ago for atypical pneumonia. Mental status exam shows slurred speech. This toxicity is due to profound CYP3A4 enzyme inhibition.
A 22-year-old woman evaluated in the outpatient clinic for new-onset oligomenorrhea, hirsutism, and a 10-kg (22-lb) weight gain. She is treated for acute mania. Physical exam shows significant facial acne. Labs reveal asymptomatic hyperammonemia and elevated serum free testosterone.
A 45-year-old man presents to the ED with exertional dyspnea and orthopnea two months after starting a new agent for treatment-refractory bipolar disorder. Past psychiatric history includes multiple failed medication trials. Physical exam reveals crackles at lung bases. Labs show elevated troponins. The medication requires strict registry monitoring for severe neutropenia.
A 31-year-old woman is evaluated in the psychiatric clinic for an intense, distressing urge to pace and inability to sit still. She was recently started on an agent for bipolar depression. Mental status exam reveals severe agitation and continuous leg tapping. This medication uniquely requires co-administration with at least 350 calories.

Matches

Show answer & explanation

Answer

The correct matches are: 1 with Lithium carbonate; 2 with Carbamazepine; 3 with Valproic acid; 4 with Clozapine; 5 with Lurasidone.
Each correct match relies on highly specific pathognomonic features of psychiatric medication toxicity: Lithium causes both NDI and Type 1 RTA; Carbamazepine is uniquely susceptible to CYP3A4 inhibitors like clarithromycin; Valproic acid induces hyperammonemia and PCOS-like changes; Clozapine requires absolute neutrophil count monitoring and causes myocarditis; and Lurasidone has a specific 350-calorie requirement along with a high risk of akathisia.

Step-by-Step Solution

1
Analyze the first presentation regarding non-anion gap metabolic acidosis and ADH-resistant polyuria.
Identifies nephrogenic diabetes insipidus (NDI) and distal renal tubular acidosis (RTA), pointing to Lithium carbonate.
Lithium interferes with aquaporin-2 channels causing NDI, and impairs distal tubular hydrogen secretion causing type 1 RTA.
2
Evaluate the second presentation involving clarithromycin administration and subsequent neurologic toxicity.
Identifies a CYP3A4 drug-drug interaction leading to toxicity, pointing to Carbamazepine.
Carbamazepine is a CYP3A4 substrate; macrolides like clarithromycin inhibit this enzyme, precipitating carbamazepine toxicity (nystagmus, ataxia).
3
Assess the third presentation featuring oligomenorrhea, hyperandrogenism, and hyperammonemia.
Recognizes medication-induced PCOS-like syndrome and hyperammonemia, pointing to Valproic acid.
Valproic acid uniquely causes both hyperammonemia (often asymptomatic) and reproductive endocrine abnormalities mimicking polycystic ovary syndrome.
4
Examine the fourth presentation involving heart failure, elevated troponins, and strict neutropenia monitoring.
Identifies drug-induced myocarditis in the setting of REMS monitoring, pointing to Clozapine.
Clozapine requires strict monitoring for absolute neutrophil count (ANC) due to agranulocytosis risk and is notoriously associated with myocarditis.
5
Analyze the fifth presentation involving a 350-calorie requirement and severe akathisia in bipolar depression.
Identifies the unique pharmacokinetic requirement and adverse effect profile of Lurasidone.
Lurasidone must be taken with at least 350 calories for adequate absorption and has a high incidence of extrapyramidal symptoms, particularly akathisia.

Key Concept

The pharmacodynamics, pharmacokinetics, and highly specific adverse effect profiles of mood stabilizers and atypical antipsychotics used in bipolar disorder.
Estimated Time:3m 0s
Question 3167Question →

A 52-year-old man with a 20-year history of severe alcohol use disorder is admitted to the medical ward for treatment of community-acquired pneumonia. He reports that his last alcoholic beverage was consumed just prior to arriving at the emergency department. To anticipate his clinical course, arrange the following classic manifestations of alcohol withdrawal syndrome in the chronological order in which they most typically first appear, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Tremulousness, mild anxiety, and diaphoresis (6-24 hours), followed by generalized tonic-clonic seizures (12-48 hours), and finally delirium, severe autonomic hyperactivity, and fever (48-96 hours).
Alcohol withdrawal follows a predictable chronological pattern based on the duration since the last drink. Minor withdrawal (tremors, diaphoresis, anxiety with intact orientation) is the earliest manifestation, starting at 6-24 hours. Withdrawal seizures typically follow at 12-48 hours. Finally, delirium tremens is the latest and most severe manifestation, usually presenting at 48-96 hours. Understanding this timeline is critical for anticipating complications and initiating appropriate prophylactic management.

Step-by-Step Solution

1
Identify the clinical scenario and the risk involved.
The patient has a history of heavy daily alcohol use and abruptly stopped drinking upon admission, putting him at high risk for alcohol withdrawal syndrome.
Recognizing the context dictates the need to anticipate the timeline of expected physiological changes.
2
Determine the typical onset of early withdrawal symptoms.
Minor withdrawal symptoms, such as tremulousness, anxiety, palpitations, and diaphoresis, are the first to appear.
These manifestations typically occur within 6 to 24 hours after the last drink.
3
Identify intermediate withdrawal manifestations.
Generalized tonic-clonic seizures typically manifest next in the timeline.
Withdrawal seizures most commonly occur 12 to 48 hours following alcohol cessation.
4
Determine the onset of late, severe withdrawal.
Delirium tremens, characterized by delirium, severe autonomic hyperactivity, and fever, is the final stage.
This life-threatening condition usually begins 48 to 96 hours after the last drink.

Key Concept

Alcohol withdrawal syndrome progresses in a predictable chronological timeline: minor withdrawal (6-24 hours), followed by withdrawal seizures and/or alcoholic hallucinosis (12-48 hours), and eventually delirium tremens (48-96 hours).
Question 3168Question →

A 28-year-old woman presents to her primary care physician reporting a 6-week history of pervasive sadness, loss of interest in her usual hobbies, significant fatigue, and difficulty concentrating at work. She has no past medical history and takes no medications. Physical examination and initial laboratory studies, including a thyroid-stimulating hormone level, are unremarkable. The physician determines she meets the criteria for a major depressive episode and considers initiating a selective serotonin reuptake inhibitor. Which of the following is the most critical historical information to obtain before prescribing this medication?

Show answer & explanation

Answer: History of unusually elevated mood and decreased need for sleep

Answer

History of unusually elevated mood and decreased need for sleep
A major depressive episode is not exclusive to major depressive disorder; it also occurs in bipolar I and bipolar II disorders. Initiating an antidepressant, such as a selective serotonin reuptake inhibitor, without a concurrent mood stabilizer in a patient with bipolar disorder can precipitate a dangerous manic or hypomanic episode (a 'manic switch'). Therefore, inquiring about past periods of elevated mood, impulsivity, and a decreased need for sleep is the most critical safety screening step before prescribing any antidepressant.

Step-by-Step Solution

1
Identify the patient's current clinical syndrome.
The patient meets criteria for a major depressive episode.
She has 6 weeks of depressed mood, anhedonia, fatigue, and poor concentration.
2
Determine the necessary safety assessments prior to initiating an antidepressant.
The physician must screen for a history of mania or hypomania.
A major depressive episode can occur in both unipolar and bipolar disorders. Antidepressant monotherapy can trigger a manic switch in bipolar patients.

Key Concept

Before initiating antidepressant monotherapy for a major depressive episode, physicians must screen for a history of manic or hypomanic episodes to prevent iatrogenic precipitation of mania.
Question 3169Question →

A 36-year-old woman comes to the clinic due to nipple discharge for the past month. She first noticed small, dark red stains on her bra. Over the past week, she has been able to express fluid from her right nipple by gently squeezing it. The fluid is frankly bloody. She has no breast pain, skin changes, or noticeable lumps. The patient's menstrual cycles are regular, occurring every 28 days, and she is nulligravida. She takes no medications and has no family history of breast or ovarian cancer. Her vital signs are within normal limits. On physical examination, both breasts are symmetric with normal skin architecture. There are no palpable breast masses or axillary lymphadenopathy. Gentle compression of the right areola elicits a few drops of bloody fluid from a single duct on the right nipple. The left breast examination is unremarkable. Which of the following is the most likely underlying pathological finding in this patient?

Show answer & explanation

Answer: Benign, papillary growth within a major lactiferous duct

Answer

The most likely pathological finding is a benign, papillary growth within a major lactiferous duct, characteristic of an intraductal papilloma.
The correct answer describes an intraductal papilloma. This benign tumor arises from the epithelial lining of the major lactiferous ducts. It is the most common cause of pathologic nipple discharge, which is classically described as unilateral, spontaneous, and bloody (sanguineous) or serosanguineous, originating from a single duct. Because these tumors are typically small (often < 1 cm), they usually do not present with a palpable breast mass or overlying skin changes. Despite its benign nature, the standard of care requires further evaluation with diagnostic imaging and potentially tissue biopsy to definitively rule out an underlying malignancy.

Step-by-Step Solution

1
Analyze the characteristics of the nipple discharge.
The discharge is unilateral, spontaneous, and bloody (sanguineous) from a single duct.
Characterizing the discharge as pathologic (unilateral, bloody/serous) versus physiologic (bilateral, milky) narrows the differential diagnosis.
2
Evaluate the associated physical examination findings.
There are no palpable breast masses, skin changes, or axillary lymphadenopathy.
The absence of a mass or skin changes (like in Paget disease) combined with bloody discharge strongly points to a small intraductal lesion.
3
Correlate the clinical picture with the most likely pathology.
The clinical picture perfectly matches an intraductal papilloma.
Intraductal papilloma is the most common cause of unilateral, bloody nipple discharge without a coexisting breast mass.

Key Concept

Intraductal papilloma is a benign breast tumor that is the most common cause of unilateral, spontaneous, bloody nipple discharge, typically presenting without a palpable mass.
Estimated Time:1m 0s
Question 3170Question →

A 27-year-old man presents to the clinic reporting sudden, unexpected episodes of intense fear, heart palpitations, diaphoresis, and shortness of breath occurring over the past month. The episodes peak within 10 minutes and resolve after approximately an hour. Between episodes, he constantly worries about having another attack. He has no known medical history. Upon taking a detailed psychiatric history, he reports a past episode where he felt "on top of the world," had a decreased need for sleep (3 hours per night), and engaged in reckless spending for two weeks, which resolved spontaneously. Vital signs and physical examination are unremarkable. An electrocardiogram shows normal sinus rhythm. Which of the following are the most appropriate initial steps in the evaluation and management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Serum thyroid-stimulating hormone level; Urine toxicology screen

Answer

The most appropriate initial steps are obtaining a serum thyroid-stimulating hormone level and a urine toxicology screen.
The correct choices identify the standard medical rule-out tests for new-onset panic attacks. A urine toxicology screen is indicated to rule out substance-induced anxiety (e.g., from cocaine or amphetamines). A serum thyroid-stimulating hormone level is necessary to rule out hyperthyroidism, which can closely mimic panic attacks by causing symptoms such as tachycardia, diaphoresis, and tremors.

Step-by-Step Solution

1
Analyze the patient's acute symptoms.
The patient is experiencing sudden, unexpected episodes of intense fear and autonomic arousal (palpitations, diaphoresis, shortness of breath) along with anticipatory anxiety, which is characteristic of panic attacks.
Identifying the primary symptom cluster guides the differential diagnosis toward anxiety disorders and their medical mimics.
2
Determine the necessary initial diagnostic workup.
Before diagnosing a primary psychiatric disorder like Panic Disorder, general medical conditions and substance use must be ruled out. A serum thyroid-stimulating hormone level and a urine toxicology screen are the standard first steps.
Hyperthyroidism and stimulant intoxication (e.g., cocaine, amphetamines) can present with symptoms identical to panic attacks.
3
Evaluate the patient's psychiatric history for comorbidities.
The patient describes a past two-week episode of euphoria, decreased need for sleep, and impulsive behavior, which meets the criteria for a manic episode. This establishes a diagnosis of Bipolar I disorder.
Identifying bipolar disorder is critical because it significantly alters the pharmacological management of co-occurring anxiety.
4
Assess the safety of pharmacological interventions.
Initiating an SSRI monotherapy (like sertraline) for panic symptoms is contraindicated due to the high risk of precipitating a manic switch in a patient with bipolar disorder.
Ensuring patient safety by avoiding contraindicated medications is a key component of management formulation.

Key Concept

The initial workup of new-onset panic attacks requires ruling out common medical and substance-induced causes (e.g., hyperthyroidism, stimulant intoxication). Additionally, a careful psychiatric history to screen for bipolar disorder is essential before initiating antidepressant monotherapy to prevent a manic switch.
Estimated Time:1m 30s
Question 3171Question →

A 54-year-old man is admitted to the hospital with acute pancreatitis. He has a 15-year history of heavy daily alcohol consumption, and his last drink was 24 hours ago. On examination, he is agitated, diaphoretic, and tremulous. Vital signs show a temperature of 37.8°C (100.0°F), blood pressure of 165/95 mm Hg, and heart rate of 118/min. Laboratory studies reveal a blood glucose of 68 mg/dL, aspartate aminotransferase (AST) of 185 U/L, alanine aminotransferase (ALT) of 82 U/L, and total bilirubin of 3.2 mg/dL. He has temporal muscle wasting and a scaphoid abdomen. The patient expresses a strong desire to achieve long-term sobriety after this hospitalization. Arrange the following steps in the most appropriate chronological order for the comprehensive management of this patient, from immediate acute stabilization to long-term relapse prevention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with acute nutritional stabilization (thiamine before glucose), followed by acute withdrawal management (lorazepam due to hepatic impairment), clinical observation until resolution of acute symptoms, and finally the initiation of long-term maintenance therapy (acamprosate).
The management of severe alcohol use disorder progresses sequentially from immediate stabilization of life-threatening deficiencies to acute withdrawal management, followed by long-term relapse prevention. Thiamine must precede glucose to prevent Wernicke encephalopathy. Benzodiazepines managed via glucuronidation (lorazepam, oxazepam, temazepam) are used for withdrawal to prevent hepatic accumulation. After withdrawal resolves, acamprosate is the preferred maintenance drug due to the patient's underlying liver dysfunction, which contraindicates naltrexone.

Step-by-Step Solution

1
Analyze the patient's immediate nutritional and metabolic needs.
The patient has hypoglycemia and signs of severe malnutrition, requiring immediate dextrose. However, thiamine must be given first.
Administering glucose without prior thiamine administration can deplete the remaining thiamine stores, precipitating Wernicke encephalopathy.
2
Determine the appropriate pharmacological management for the acute withdrawal symptoms.
The patient is experiencing acute alcohol withdrawal and has evidence of alcoholic hepatitis (AST:ALT ratio > 2, elevated bilirubin).
Lorazepam is preferred because it relies exclusively on glucuronidation (Phase II metabolism) and does not accumulate in patients with hepatic impairment, unlike long-acting agents such as chlordiazepoxide or diazepam.
3
Identify the necessary transition criteria from acute detoxification to chronic management.
The patient must be closely monitored until acute autonomic symptoms and agitation completely resolve.
Long-term maintenance therapy is most effective and safe when initiated after the acute detoxification phase has concluded.
4
Select the most appropriate long-term pharmacotherapy for relapse prevention.
Acamprosate is selected as the maintenance agent upon preparation for discharge.
Naltrexone is contraindicated in patients with severe hepatic impairment or acute hepatitis. Acamprosate is renally excreted and is safe for this patient.

Key Concept

Chronological Management of Severe Alcohol Use Disorder with Hepatic Impairment
Question 3172Question →

Assess the following diverse clinical presentations of patients experiencing fear-based or stress-related psychiatric symptoms. Select the most appropriate diagnosis for each patient presentation based on symptom duration and clinical characteristics.

Click a left item, then click its matching right item

Items

A patient experiences unexpected, abrupt surges of intense fear with palpitations, followed by persistent concern about having additional episodes for the past two months.
A patient develops intrusive nightmares, hypervigilance, negative mood, and dissociative symptoms lasting for exactly three weeks after surviving a life-threatening industrial accident.
A patient demonstrates marked, unreasonable fear and avoidance of flying on airplanes for the past eight months, without fear of other enclosed spaces or public transit.
A patient reports nine months of pervasive, uncontrollable worry about multiple everyday domains, accompanied by chronic muscle tension, irritability, and sleep disturbance.
A patient develops significant anxiety and mild depressive symptoms causing academic decline, beginning shortly after a non-life-threatening relationship breakup two months ago.

Matches

Show answer & explanation

Answer

The correct matches align each clinical vignette with its DSM-5 diagnostic category based on specific symptom duration thresholds and trigger characteristics.
Each vignette provides pathognomonic combinations of symptom type, duration, and triggering events that exclusively align with one specific DSM-5 diagnostic category in the anxiety and trauma spectrum.

Step-by-Step Solution

1
Analyze the first patient's presentation of unexpected abrupt fear followed by persistent concern.
Matches Panic disorder.
The key criterion is the presence of unexpected panic attacks followed by at least 1 month of anticipatory anxiety about future attacks.
2
Evaluate the second patient's post-trauma symptoms lasting exactly three weeks.
Matches Acute stress disorder.
Trauma-related symptoms lasting between 3 days and 1 month define Acute stress disorder. If symptoms persist beyond 1 month, the diagnosis changes to PTSD.
3
Assess the third patient's isolated fear of flying lasting eight months.
Matches Specific phobia.
Persistent fear of a single specific situation lasting 6 or more months defines Specific phobia. The absence of other feared situations excludes agoraphobia.
4
Review the fourth patient's pervasive worry and muscle tension lasting nine months.
Matches Generalized anxiety disorder.
Uncontrollable worry across multiple domains lasting at least 6 months with associated physical symptoms like muscle tension is the hallmark of GAD.
5
Analyze the fifth patient's symptom onset following a relationship breakup two months ago.
Matches Adjustment disorder.
Symptoms developing within 3 months of a psychosocial stressor and causing functional impairment, without meeting criteria for another disorder, characterize Adjustment disorder.

Key Concept

Accurate psychiatric diagnosis relies on identifying the nature of the triggering event (e.g., severe trauma, non-life-threatening stressor, specific object, or unexpected panic) and verifying that the symptom duration meets DSM-5 time thresholds.
Estimated Time:1m 30s
Question 3173Question →

An 81-year-old man is brought to the primary care clinic by his son due to a 9-month history of gradual memory decline. The son reports that the patient frequently repeats questions, has stopped managing his own finances, and recently got lost while walking in his familiar neighborhood. The patient has a history of hypertension and osteoarthritis. Vital signs are within normal limits, and the physical examination is unremarkable. After completing a thorough clinical history and medication review, arrange the following steps in the diagnostic evaluation of this patient's suspected neurocognitive disorder in the most appropriate chronological order, from the immediate next step to advanced workup.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential workup for suspected neurocognitive disorder begins with objective cognitive screening, followed by laboratory testing for reversible causes, structural neuroimaging, and finally, advanced testing (such as PET or CSF biomarkers) only if the diagnosis remains atypical or unclear.
The standard diagnostic pathway for a new presentation of cognitive decline requires confirming the deficit clinically first (using a tool like the MoCA), then ruling out reversible systemic causes (with basic labs like TSH and B12), followed by ruling out structural brain lesions (with an MRI or CT). Advanced functional or biomarker testing is only pursued if these initial steps do not yield a clear clinical picture.

Step-by-Step Solution

1
Identify the need for objective verification of the reported cognitive decline.
Standardized cognitive assessment (e.g., MoCA) is selected as the immediate next step.
Subjective reports from family must be quantified and objectively documented before initiating a medical workup.
2
Determine the initial medical workup to rule out reversible etiologies.
Targeted laboratory tests (TSH, B12, CMP, CBC) are ordered.
Metabolic and endocrine abnormalities must be excluded as they can mimic or exacerbate major neurocognitive disorders.
3
Select the appropriate initial imaging modality.
Structural MRI of the brain is ordered.
Structural imaging is a standard part of the dementia workup to rule out macroscopic intracranial pathology like strokes, masses, or hydrocephalus.
4
Determine the role of advanced diagnostic modalities.
Functional imaging or CSF biomarkers are reserved for the end of the pathway.
These tests are expensive, invasive, or specialized, and are only indicated if the standard sequential workup is inconclusive.

Key Concept

Sequential Diagnostic Evaluation of Major Neurocognitive Disorder
Question 3174Question →

For each patient vignette describing a mood-related presentation, select the most appropriate primary treatment modality or specific medication.

Click a left item, then click its matching right item

Items

A 78-year-old retired architect presenting with profound psychomotor retardation, delusions that his organs are rotting, and complete refusal of food and water for five days.
A 54-year-old office manager who developed persistent anhedonia, early morning awakenings, and severe guilt three weeks after surviving an acute anterior myocardial infarction.
A 31-year-old freelance writer with current debilitating hypersomnia and low mood, whose medical records indicate a previous four-day episode of pressured speech and decreased need for sleep.
A 28-year-old physical therapist with a new-onset major depressive episode who explicitly requests a medication that will not cause weight gain or sexual dysfunction.

Matches

Show answer & explanation

Answer

The correct matches align specific clinical presentations of depression with their evidence-based treatments: severe inanition/psychosis with electroconvulsive therapy, post-myocardial infarction status with sertraline, bipolar depression with quetiapine, and concern for sexual side effects with bupropion.
Each match represents the standard of care for a specific depressive presentation. Electroconvulsive therapy is rapidly acting and life-saving for psychotic depression with inanition. Sertraline has the best cardiovascular safety profile for post-myocardial infarction patients. Quetiapine effectively treats bipolar depression without the risk of a manic switch associated with SSRI monotherapy. Bupropion is a norepinephrine-dopamine reuptake inhibitor that lacks the sexual dysfunction and weight gain typical of SSRIs.

Step-by-Step Solution

1
Analyze the 78-year-old patient's presentation.
Identified psychotic depression with life-threatening food and fluid refusal.
Dictates the need for a rapid, definitive intervention rather than waiting weeks for pharmacotherapy to take effect.
2
Evaluate the 54-year-old patient's medical history.
Noted the very recent acute anterior myocardial infarction.
Cardiovascular safety is the primary limiting factor when selecting an antidepressant for this patient population.
3
Review the 31-year-old patient's psychiatric history.
Identified a past hypomanic episode (4 days of decreased sleep and pressured speech).
Changes the diagnosis from unipolar to bipolar depression, fundamentally altering the pharmacologic approach.
4
Consider the 28-year-old patient's specific treatment preferences.
Identified the requirement to avoid weight gain and sexual dysfunction.
Guides the selection away from standard SSRIs toward an atypical agent with a different receptor profile.

Key Concept

Tailoring management of depressive disorders to patient-specific psychiatric comorbidities, medical history, and medication side effect profiles.
Question 3175Question →

A 26-year-old male graduate student presents to the student health clinic complaining of severe exhaustion and low mood for the past month. He states he has no energy to attend lectures, sleeps 12 hours a day, and has lost interest in playing the guitar, which is his favorite hobby. He describes feeling immensely guilty over his lack of productivity. Upon further questioning, he reveals that two years ago he experienced a distinct 3-week period where he required only 2 hours of sleep per night, felt 'full of brilliant ideas,' and maxed out his credit cards buying equipment to start a music production company. That episode resolved without medical intervention. He currently takes no medications and has no history of substance use. The physician is planning to initiate pharmacological therapy for his current presentation.

Which of the following are appropriate pharmacological interventions for this patient's current episode? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Monotherapy with quetiapine; Monotherapy with cariprazine

Answer

The correct pharmacological interventions are monotherapy with quetiapine and monotherapy with cariprazine.
The correct answers provide appropriate, evidence-based treatments for acute bipolar depression. The patient's history of an elevated mood, decreased need for sleep, and severe impulsivity lasting three weeks meets the criteria for a past manic episode, confirming a diagnosis of Bipolar I Disorder. First-line therapies for bipolar depression include specific second-generation antipsychotics such as quetiapine, cariprazine, and lurasidone. These agents effectively treat depressive symptoms while inherently protecting against a manic switch.

Step-by-Step Solution

1
Analyze the clinical history to establish the correct psychiatric diagnosis.
The patient has a current major depressive episode and a history of a severe manic episode, fulfilling the criteria for Bipolar I Disorder.
Recognizing a past manic episode is crucial, as treating bipolar depression requires a fundamentally different pharmacological approach than unipolar depression.
2
Identify the standard of care for treating an acute depressive episode in Bipolar I Disorder.
First-line treatments include specific mood stabilizers and select second-generation antipsychotics, such as quetiapine, cariprazine, or lurasidone.
These medications have demonstrated efficacy in alleviating bipolar depression without inducing mood elevation.
3
Evaluate the treatment choices and rule out contraindicated therapies.
Quetiapine and cariprazine monotherapy are appropriate. Sertraline, venlafaxine, and bupropion monotherapy are incorrect.
Antidepressant monotherapy is generally contraindicated in bipolar disorder because it can precipitate a manic switch or rapid cycling.

Key Concept

The treatment of acute bipolar depression requires specific second-generation antipsychotics (e.g., quetiapine, cariprazine) or mood stabilizers, while explicitly avoiding antidepressant monotherapy due to the high risk of inducing a manic switch.
Estimated Time:1m 15s
Question 3176Question →

A 24-year-old man is brought to the clinic by his sister due to bizarre behavior. For the past 3 months, he has been hearing voices telling him that he is on a special mission, and he believes that the government is monitoring his thoughts. His sister notes that he has stopped going to work and spends most of his time in his room. He has no history of medical illnesses, and a urine toxicology screening is negative. He does not display any symptoms of depression or mania. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophreniform disorder

Answer

Schizophreniform disorder
The correct diagnosis is schizophreniform disorder. The patient exhibits active-phase symptoms of psychosis (delusions and auditory hallucinations) along with a decline in functioning. The most critical factor in this vignette is the duration of these symptoms, which is 3 months. According to diagnostic criteria, psychotic symptoms lasting between 1 month and 6 months define schizophreniform disorder.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms.
The patient exhibits auditory hallucinations, delusions, and a significant decline in social and occupational functioning.
To establish that the patient is experiencing a primary psychotic episode.
2
Identify the total duration of the psychotic symptoms.
The history provided by the sister indicates that symptoms have been present for exactly 3 months.
Symptom duration is the primary criterion used to differentiate among acute psychotic disorders.
3
Apply the diagnostic criteria timelines for primary psychotic disorders.
A duration of 3 months falls precisely into the 1 to 6-month diagnostic window.
Brief psychotic disorder lasts less than 1 month, schizophreniform disorder lasts between 1 and 6 months, and schizophrenia lasts greater than 6 months.

Key Concept

The primary distinguishing factor among brief psychotic disorder, schizophreniform disorder, and schizophrenia is the duration of symptoms (less than 1 month, 1 to 6 months, and greater than 6 months, respectively).
Question 3177Question →

An accompanied 71-year-old male patient presents to the geriatrics clinic for the evaluation of distressing 'visions' that have worsened over the past 11 months. According to his daughter, who lives with him, the patient frequently sees unfamiliar people sitting in their living room. These detailed visual hallucinations cause him severe agitation. Over the same timeframe, his cognitive abilities have declined, characterized by pronounced day-to-day fluctuations in attention and alertness. The daughter also reports that he often shouts and thrashes during sleep. Physical examination reveals an expressionless face, right-sided resting tremor, and cogwheel rigidity in the upper extremities. Initial non-pharmacological management, including environmental modifications, has failed to alleviate his distress. Which of the following is the most appropriate initial pharmacological therapy for this patient's visual hallucinations?

Show answer & explanation

Answer: Rivastigmine

Answer

The correct answer is Rivastigmine.
Acetylcholinesterase inhibitors, such as rivastigmine, are the preferred first-line pharmacological therapy for cognitive and behavioral symptoms in patients with major neurocognitive disorder with Lewy bodies (DLB). When non-pharmacological interventions fail to control distressing visual hallucinations, rivastigmine is recommended because it often improves these neuropsychiatric symptoms without the severe risks associated with antipsychotic medications in this patient population.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has a progressive neurocognitive disorder, fluctuating cognition, detailed visual hallucinations, REM sleep behavior disorder (thrashing during sleep), and spontaneous parkinsonism.
Identifying these four core clinical features establishes the underlying diagnosis of major neurocognitive disorder with Lewy bodies (DLB).
2
Identify the primary symptom requiring management.
The primary issue is severe, distressing visual hallucinations that have not responded to non-pharmacological interventions.
Management in DLB is symptom-specific, and non-pharmacological approaches are always the first step. Since they failed, pharmacotherapy is indicated.
3
Determine the first-line pharmacological therapy for this symptom in DLB.
Acetylcholinesterase inhibitors (AChEIs) such as rivastigmine or donepezil are indicated as the first-line pharmacological treatment.
Unlike primary psychotic disorders where antipsychotics are first-line, psychosis in DLB responds well to AChEIs, which avoid the high mortality and morbidity risks associated with antipsychotics in this population.

Key Concept

Acetylcholinesterase inhibitors (e.g., rivastigmine, donepezil) are the first-line pharmacological treatment for neuropsychiatric symptoms, including distressing visual hallucinations, in patients with Dementia with Lewy Bodies (DLB).
Estimated Time:1m 15s
Question 3178Question →

Paramedics bring a 24-year-old female university student to the acute care clinic after her roommates found her unresponsive on the couch. Her temperature is 36.5°C (97.7°F), blood pressure is 105/62 mm Hg, pulse is 55/min, and respiratory rate is 6/min. Pulse oximetry shows an oxygen saturation of 86% on room air. On physical examination, the patient is somnolent and minimally responsive to sternal rub. Cardiopulmonary auscultation reveals shallow but clear breath sounds bilaterally and a bradycardic but regular heart rhythm. Pupillary examination demonstrates 1.5-mm pupils bilaterally that are sluggishly reactive to light. Bowel sounds are diminished. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer intravenous naloxone

Answer

Administer intravenous naloxone
The correct answer is administering intravenous naloxone. The patient's clinical presentation—characterized by profound respiratory depression (respiratory rate of 6/min), altered mental status, and pinpoint pupils (miosis)—is the hallmark triad of acute opioid intoxication. In this scenario, the immediate life-threatening issue is respiratory failure. Naloxone is a competitive mu-opioid receptor antagonist that rapidly reverses opioid-induced respiratory depression and should be given immediately in the acute care setting.

Step-by-Step Solution

1
Analyze the vital signs and physical examination findings.
The patient has severe hypoventilation (RR 6/min), hypoxia (SpO2 86%), bradycardia, altered mental status, and pinpoint pupils (1.5 mm).
Identifying the constellation of physical signs is necessary to recognize the specific toxidrome.
2
Formulate a clinical diagnosis based on the classic triad of symptoms.
The combination of central nervous system depression, respiratory depression, and miosis strongly indicates acute opioid intoxication.
Opioid receptors in the central nervous system modulate both respiratory drive and pupillary constriction.
3
Determine the most appropriate immediate intervention for this toxidrome.
The patient requires immediate administration of an opioid antagonist (naloxone).
Naloxone displaces opioids from the mu-opioid receptors, rapidly reversing life-threatening respiratory depression.

Key Concept

The classic presentation of opioid intoxication includes depressed mental status, respiratory depression, and miosis. The definitive acute management is the administration of the opioid antagonist naloxone.
Estimated Time:1m 0s
Question 3179Question →

Match each clinical presentation to the most appropriate psychiatric diagnosis based on symptom duration and characteristics.

Click a left item, then click its matching right item

Items

Sudden onset of auditory hallucinations and disorganized speech lasting 2 weeks, followed by a full return to baseline functioning.
Prominent auditory hallucinations and disorganized behavior present for 4 months, without any mood symptoms.
Delusions of persecution and flat affect causing progressive functional decline for the past 8 months.
Fixed, false belief of being poisoned by a neighbor for 3 months, with no hallucinations and normal daily functioning.

Matches

Show answer & explanation

Answer

The correct matches are based strictly on duration and symptom cluster: 2 weeks corresponds to Brief psychotic disorder; 4 months corresponds to Schizophreniform disorder; 8 months corresponds to Schizophrenia; and an isolated delusion for 3 months with preserved functioning corresponds to Delusional disorder.
The correct matches rely directly on the DSM-5 timeline criteria for psychotic disorders. Less than 1 month of symptoms is brief psychotic disorder. Between 1 and 6 months of symptoms is schizophreniform disorder. Greater than 6 months of symptoms is schizophrenia. A presentation with only delusions for at least 1 month without significant functional decline or other psychotic symptoms is delusional disorder.

Step-by-Step Solution

1
Analyze the duration of the psychotic symptoms for each clinical presentation.
The identified durations are 2 weeks, 4 months, 8 months, and 3 months.
Symptom duration is the primary differentiating factor among brief psychotic disorder (< 1 month), schizophreniform disorder (1-6 months), and schizophrenia (> 6 months).
2
Evaluate the symptom profile to isolate specific disorders.
The 3-month presentation features only a single delusion with normal daily functioning, unlike the other presentations which feature multiple psychotic domain symptoms like hallucinations and disorganized speech.
Delusional disorder requires intact overall functioning and the absence of prominent hallucinations or disorganized speech.

Key Concept

Differentiation of psychotic disorders by symptom duration and clinical presentation
Question 3180Question →

A 34-year-old male combat veteran presents to the psychiatric outpatient clinic seeking help for severe irritability, insomnia, and intrusive memories. He returned from a combat deployment 14 months ago and has since struggled to reintegrate into civilian life. He avoids crowded places, refuses to watch war movies, and describes feeling "constantly on guard." His wife reports that he frequently wakes up thrashing and sweating. A review of his past medical records reveals a psychiatric hospitalization at age 23 for a 2-week episode of euphoric mood, flight of ideas, and severely decreased need for sleep, which resulted in significant financial debt. He is currently not taking any medications and denies any illicit substance use, though he admits to drinking 4-5 beers nightly to help him sleep.

Which of the following is the most appropriate initial pharmacologic step in the management of this patient's symptoms?

Show answer & explanation

Answer: Initiate quetiapine monotherapy

Answer

Initiate quetiapine monotherapy
The patient's current presentation of intrusive memories, avoidance, hypervigilance, and insomnia lasting for 14 months following combat exposure is highly characteristic of Post-Traumatic Stress Disorder (PTSD). However, his history of a 2-week episode of euphoric mood, flight of ideas, and decreased need for sleep requiring hospitalization firmly establishes a diagnosis of Bipolar I Disorder. While selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are the standard first-line pharmacotherapy for PTSD, antidepressant monotherapy is strictly contraindicated in patients with Bipolar I Disorder due to the high risk of precipitating a manic episode (manic switch). In patients with comorbid PTSD and Bipolar Disorder, the primary pharmacological goal is mood stabilization. An atypical antipsychotic, such as quetiapine, serves as an effective mood stabilizer to prevent manic episodes while its specific pharmacodynamic profile concurrently treats the hyperarousal, severe anxiety, and insomnia associated with PTSD.

Step-by-Step Solution

1
Diagnose the current acute presentation.
The patient has Post-Traumatic Stress Disorder (PTSD) based on >1 month of intrusive memories, avoidance, hyperarousal, and sleep disturbance following combat exposure.
Establishing the current psychiatric syndrome is necessary to determine the therapeutic target.
2
Identify any critical comorbid psychiatric diagnoses from the medical history.
The patient has a history of a 2-week manic episode (euphoria, flight of ideas, decreased need for sleep, hospitalization), establishing a diagnosis of Bipolar I Disorder.
Comorbidities profoundly alter pharmacologic treatment algorithms, particularly in mood and anxiety disorders.
3
Evaluate standard first-line treatments for PTSD against the patient's comorbidity.
SSRIs (e.g., sertraline) and SNRIs (e.g., venlafaxine) are standard for PTSD, but they are contraindicated as monotherapy in Bipolar I Disorder due to the high risk of a manic switch.
Safety parameters dictate that mood stabilization must take precedence over standard antidepressant anxiety treatment.
4
Select a medication that safely addresses both conditions.
Quetiapine is selected because it acts as a mood stabilizer (preventing mania) while its sedating and anxiolytic properties effectively target PTSD hyperarousal and insomnia.
Atypical antipsychotics are appropriate dual-purpose agents in patients where standard antidepressants are contraindicated.

Key Concept

In patients with comorbid Post-Traumatic Stress Disorder and Bipolar I Disorder, standard first-line antidepressant monotherapy (SSRIs/SNRIs) is contraindicated due to the risk of manic switch; mood stabilizers or atypical antipsychotics must be utilized instead.
PreviousPage 159 / 414Next
All practice questions — USMLE Step 2 CK | Examkin